Cecilia G Unson

Title: Cecilia G. Unson: Innovator in Glucagon Analog Research

Introduction

Cecilia G. Unson is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biochemistry, particularly in the development of glucagon analogs. With a total of 3 patents to her name, her work has been instrumental in advancing insulin therapy.

Latest Patents

Cecilia's latest patents include innovative glucagon analogs characterized by specific amino acid substitutions. One of her notable patents describes glucagon analogs with serine replacements, which are useful adjuncts to insulin therapy. These analogs are characterized principally by the substitution of amino acid residues at positions 9, 11, 16, and 21, with or without a histidine residue at the amino terminus. Another patent focuses on glucagon analogs that involve the removal or replacement of the 9-aspartic acid residue, along with the replacement of the 16-serine residue. This patent also discusses the possible replacement of the 11-serine residue and 21-aspartic acid residue, which are beneficial in insulin therapy.

Career Highlights

Cecilia G. Unson has established herself as a leading figure in her field through her innovative research and patent contributions. Her work has garnered attention for its potential to improve diabetes management and treatment options.

Collaborations

Cecilia collaborates with esteemed colleagues, including Robert B. Merrifield, to further her research and development efforts.

Conclusion

Cecilia G. Unson's contributions to glucagon analog research highlight her role as an influential inventor in the field of biochemistry. Her innovative patents continue to pave the way for advancements in insulin therapy.